Haemonetics Corporation (HAE)

Current ratio

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Total current assets US$ in thousands 768,903 764,982 865,744 801,607 769,722 706,309 715,789 687,783 756,031 729,455 699,246 684,368 693,546 668,348 760,279 759,410 603,639 582,575 567,789 615,278
Total current liabilities US$ in thousands 300,383 261,755 264,215 236,939 251,816 226,889 262,175 180,487 442,266 355,411 288,470 228,339 253,495 194,384 338,568 407,827 274,822 256,692 240,066 293,665
Current ratio 2.56 2.92 3.28 3.38 3.06 3.11 2.73 3.81 1.71 2.05 2.42 3.00 2.74 3.44 2.25 1.86 2.20 2.27 2.37 2.10

March 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $768,903K ÷ $300,383K
= 2.56

Haemonetics Corporation's current ratio has exhibited fluctuations over the past few quarters. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. A higher current ratio is generally indicative of stronger liquidity and financial health.

As of March 31, 2024, the current ratio stands at 2.56, which indicates that the company has $2.56 in current assets for every $1 in current liabilities. This ratio has decreased from the previous quarter, where it was 2.92, and is lower than the company's performance in the second and third quarters of 2023.

Looking further back, Haemonetics Corporation showed a notable decline in the current ratio in the first quarter of 2022, reaching 1.71. However, the ratio improved significantly in the second quarter of 2022, peaking at 3.81, suggesting a strong liquidity position at that time.

Overall, the current ratio fluctuates, indicating varying levels of liquidity and ability to meet short-term obligations. Investors and analysts may want to examine the underlying reasons for these fluctuations to assess the company's financial stability and operational efficiency.


Peer comparison

Mar 31, 2024